Krsnaa Diagnostics Ltd Share Price & Stock Analysis

Krsnaa Diagnostics Ltd (NSE: KRSNAA, BSE: 543328) is a Pune, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹1,625 Cr, it ranks #1,345 by market cap among the 6,197 Indian listed companies on FinBizNet, and #6 of 18 in Medical Diagnostic Centres. At ₹530.00 (as of 16 Nov 2026), the share price is 36.8% below its 52-week high of ₹838.00 and 14.4% above its 52-week low of ₹463.10. The share price is down 27.0% over one year and down 5.0% over three months.

Key Metrics

Current Price₹530.00
Market Cap₹1,625 Cr
NSE SymbolKRSNAA
BSE Code543328
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Services > Medical Diagnostic Centres
P/E Ratio16.8
Return on Equity10.89%
Return on Assets4.89%
52-Week Range₹463.10 – ₹838.00
1-Year Price Change-27.0%
3-Month Price Change-5.0%
Beta (1Y)0.37
Dividend Yield0.39%
HeadquartersPune, Maharashtra
Websitekrsnaadiagnostics.com

Latest Quarterly Results — Q2 FY27

Revenue₹271 Cr
Net Profit₹25 Cr
Net Margin9.1%
EPS (Basic)₹7.64
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Krsnaa Diagnostics Ltd Quarterly Revenue and Profit Trend

Krsnaa Diagnostics Ltd reported revenue of ₹271 Cr in Q2 FY27, up 31.5% from ₹206 Cr in Q2 FY26 and up 15.0% from ₹236 Cr in Q1 FY27. It posted a net profit of ₹25 Cr for the quarter, against a net profit of ₹24 Cr in Q2 FY26 (up 2.7%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹181 Cr (Q3 FY26) to ₹271 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹271 Cr₹25 Cr9.1%
Q1 FY27₹236 Cr₹17 Cr7.0%
Q4 FY26₹193 Cr₹42 Cr21.7%
Q3 FY26₹181 Cr₹15 Cr8.4%
Q2 FY26₹206 Cr₹24 Cr11.6%
Q1 FY26₹193 Cr₹21 Cr10.6%
Q4 FY25₹186 Cr₹21 Cr11.1%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 27.11% of Krsnaa Diagnostics Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 52.7% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.

Products and Services

1. Radiology and Pathology Services-This segment provides diagnostic services. It offers radiology and pathology services for X-ray, CT-scan, MRI, mammography, tele-reporting, and various types of blood and urine investigations.

Business Segments

1. Diagnostic Services in Radiology and Pathology Services-100%

Krsnaa Diagnostics Ltd vs Peers — Medical Diagnostic Centres

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Dr. Lal Pathlabs Ltd₹33,934 Cr66.421.48%₹874 Cr+28.7%
Vijaya Diagnostic Centre Limited₹14,665 Cr84.319.70%₹255 Cr+38.5%
Metropolis Healthcare Limited₹11,952 Cr61.513.37%₹497 Cr+14.9%
Throcare Technologies Ltd₹7,764 Cr47.628.74%₹271 Cr+7.5%
SURAKSHA DIAGNOSTIC LIMITED₹1,856 Cr55.413.84%₹99 Cr+6.9%
Krsnaa Diagnostics Ltd₹1,625 Cr16.810.89%₹271 Cr-27.0%
Gaudium IVF and Women Health Limited₹803 Cr27.416.08%₹37 Cr—
Chandan Healthcare Limited₹582 Cr21.918.43%₹81 Cr—
Aspira Pathlab & Diagnostics Ltd₹127 Cr2,360——+115.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Krsnaa Diagnostics Ltd?

Krsnaa Diagnostics Ltd is trading at ₹530.00, with a market capitalisation of ₹1,625 Cr.

Which sector does Krsnaa Diagnostics Ltd belong to?

Krsnaa Diagnostics Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).

What are the key financial ratios of Krsnaa Diagnostics Ltd?

Krsnaa Diagnostics Ltd has a P/E of 16.8 and a return on equity of 10.89%.

What is the stock symbol of Krsnaa Diagnostics Ltd?

Krsnaa Diagnostics Ltd is listed on the NSE under the symbol KRSNAA and on the BSE under the scrip code 543328.

How has Krsnaa Diagnostics Ltd's share price moved over the past year?

Krsnaa Diagnostics Ltd's share price is down 27.0% over one year and down 5.0% over three months. Its 52-week range is ₹463.10 to ₹838.00.

What were Krsnaa Diagnostics Ltd's latest quarterly results?

In Q2 FY27, Krsnaa Diagnostics Ltd reported revenue of ₹271 Cr and net profit of ₹25 Cr, with basic EPS of ₹7.64 (consolidated, parsed from the company's exchange filing).

How have Krsnaa Diagnostics Ltd's revenue and profit changed over the past year?

Krsnaa Diagnostics Ltd reported revenue of ₹271 Cr in Q2 FY27, up 31.5% from ₹206 Cr in Q2 FY26 and up 15.0% from ₹236 Cr in Q1 FY27.

What is the promoter holding in Krsnaa Diagnostics Ltd?

Promoters held 27.11% of Krsnaa Diagnostics Ltd's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.